PUUMALA VIRUS NEPHROPATHY

Clinical trials for PUUMALA VIRUS NEPHROPATHY explained in plain language.

Never miss a new study

Get alerted when new PUUMALA VIRUS NEPHROPATHY trials appear

Sign up with your email to follow new studies for PUUMALA VIRUS NEPHROPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New DNA shots aim to stop deadly rodent virus

⭐️ VACCINE ⭐️ Completed

This study tested two DNA vaccines designed to prevent hemorrhagic fever with renal syndrome caused by Hantaan and Puumala viruses. Healthy adults aged 18-49 received up to four doses via a needle-free jet injector. The goal was to see if the vaccines trigger a strong immune resp…

Matched conditions: PUUMALA VIRUS NEPHROPATHY

Phase: PHASE2 • Sponsor: U.S. Army Medical Research and Development Command • Aim: ⭐️ VACCINE ⭐️

Last updated May 31, 2026 21:41 UTC

PUUMALA VIRUS NEPHROPATHY

Get alerted when new PUUMALA VIRUS NEPHROPATHY trials appear

New DNA shots aim to stop deadly rodent virus